Qube Research & Technologies (QRT)
MXCT icon

Qube Research & Technologies (QRT)’s MaxCyte MXCT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,897
Closed -$20.4K – 3938
2025
Q3 		$20.4K Buy
+12,897
New +$22.4K ﹤0.01% 3290
2024
Q2 		– Sell
-17,535
Closed -$73.5K – 4427
2024
Q1 		$73.5K Buy
17,535
+11,690
+200% +$54.9K ﹤0.01% 3407
2023
Q4 		$27.5K Sell
5,845
-25,066
-81% -$97.6K ﹤0.01% 3433
2023
Q3 		$96.4K Buy
+30,911
New +$124K ﹤0.01% 2664
2022
Q3 		– Sell
-20,930
Closed -$99K – 2830
2022
Q2 		$99K Sell
20,930
-19,119
-48% -$94.2K ﹤0.01% 1955
2022
Q1 		$280K Buy
+40,049
New +$273K ﹤0.01% 1821

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MXCT Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of MaxCyte (MXCT) in Q4 2025, closing a stake of 12,897 shares — an estimated $20.4K sold.

Qube Research & Technologies (QRT) first reported a position in MXCT in Q1 2022 and held it in 6 quarters. The position peaked at $280K in Q1 2022. 112 funds tracked by Wall St. Rank hold MXCT as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining MaxCyte position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 12,897 MaxCyte shares in Q4 2025, an estimated $20.4K.
  • Qube Research & Technologies (QRT) first reported a position in MaxCyte in Q1 2022 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s MaxCyte position peaked at $280K in Q1 2022.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.